| pubmed-article:1695607 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1695607 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1695607 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:1695607 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
| pubmed-article:1695607 | lifeskim:mentions | umls-concept:C0205103 | lld:lifeskim |
| pubmed-article:1695607 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:1695607 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
| pubmed-article:1695607 | lifeskim:mentions | umls-concept:C1517942 | lld:lifeskim |
| pubmed-article:1695607 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1695607 | pubmed:dateCreated | 1990-8-30 | lld:pubmed |
| pubmed-article:1695607 | pubmed:abstractText | This is an analysis of the long-term follow-up data of 99 patients receiving HOAP-Bleo, IMVP-16 and PAC as salvage chemotherapy for refractory or relapsed intermediate or high grade non-Hodgkin's lymphomas. Most of the patients received HOAP-Bleo or PAC following failure of initial chemotherapy and IMVP-16 was used mainly for HOAP-Bleo failures. The longest follow-up time of the surviving patients was 108 months. Twenty-two and 29 per cent of the patients survived beyond 2 years following HOAP-Bleo and PAC respectively. The treatment outcome following IMVP-16 was worst with a 2-year survival of only 5 per cent, as it was used mainly following HOAP-Bleo failures. Although the prognosis of these refractory or relapsed cases are poor, salvage treatment is still worthwhile as a small proportion of these patients may have long-lasting remissions and occasional patients may be cured. Newer approaches such as autologous bone marrow transplantation should be compared with current salvage chemotherapy regimens. | lld:pubmed |
| pubmed-article:1695607 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1695607 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1695607 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1695607 | pubmed:issn | 0278-0232 | lld:pubmed |
| pubmed-article:1695607 | pubmed:author | pubmed-author:OHIKK | lld:pubmed |
| pubmed-article:1695607 | pubmed:author | pubmed-author:ToddDD | lld:pubmed |
| pubmed-article:1695607 | pubmed:author | pubmed-author:HoF FFF | lld:pubmed |
| pubmed-article:1695607 | pubmed:author | pubmed-author:ChanT KTK | lld:pubmed |
| pubmed-article:1695607 | pubmed:author | pubmed-author:ChiuE KEK | lld:pubmed |
| pubmed-article:1695607 | pubmed:author | pubmed-author:LokeS LSL | lld:pubmed |
| pubmed-article:1695607 | pubmed:author | pubmed-author:LiangR HRH | lld:pubmed |
| pubmed-article:1695607 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1695607 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:1695607 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1695607 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1695607 | pubmed:pagination | 133-40 | lld:pubmed |
| pubmed-article:1695607 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:meshHeading | pubmed-meshheading:1695607-... | lld:pubmed |
| pubmed-article:1695607 | pubmed:articleTitle | Long-term follow-up of patients receiving salvage chemotherapy for intermediate and high grade non-Hodgkin's lymphomas. | lld:pubmed |
| pubmed-article:1695607 | pubmed:affiliation | Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam. | lld:pubmed |
| pubmed-article:1695607 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1695607 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
